GCP training has become the industry standard for meeting sponsors’ responsibility to ensure qualified investigators. Despite the widespread use of this training, little evidence has been collected to determine whether it provides the knowledge and skills necessary to support investigators and their delegates in the quality conduct of clinical trials. In addition, the burden of training that is redundant or of little value, often required before each clinical trial, could make it untenable for investigators to participate in future trials. Rather than accepting GCP training as the default solution for qualifying investigators, the Clinical Trials Transformation Initiative’s multi-stakeholder project team has worked to gain a broader, evidence-based perspective to inform the efficient and effective qualification of site investigators for the quality conduct of clinical trials. Come learn about their findings.
Contact Hours/CEUs: 1.0 (ACHE, ACRP, CME, CNE)
- Sabrina Comic-Savic, The Medicines Company
- Bridget Foltz, FDA
- Janette Panhuis, BscN, MBA, Chief Operating Officer, PHRI
- Christine Pierre, Society for Clinical Research Sites